Cas:1061682-96-9 2,8-Diazaspiro[4.5]decane-8-carboxylic acid, 2-(1-methylethyl)-, 1,1-dimethylethyl ester manufacturer & supplier

We serve Chemical Name:2,8-Diazaspiro[4.5]decane-8-carboxylic acid, 2-(1-methylethyl)-, 1,1-dimethylethyl ester CAS:1061682-96-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2,8-Diazaspiro[4.5]decane-8-carboxylic acid, 2-(1-methylethyl)-, 1,1-dimethylethyl ester

Chemical Name:2,8-Diazaspiro[4.5]decane-8-carboxylic acid, 2-(1-methylethyl)-, 1,1-dimethylethyl ester
CAS.NO:1061682-96-9
Synonyms:tert-butyl 2-hydroxypent-4-enylcarbamate
Molecular Formula:C17H32N2O2
Molecular Weight:296.44800
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:32.78000
Exact Mass:296.24600
LogP:3.38370

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like tert-butyl 2-hydroxypent-4-enylcarbamate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,tert-butyl 2-hydroxypent-4-enylcarbamate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,tert-butyl 2-hydroxypent-4-enylcarbamate Use and application,tert-butyl 2-hydroxypent-4-enylcarbamate technical grade,usp/ep/jp grade.


Related News: It is frequently associated with the presence of blasts or leukemic cells in the marrow. 2,8-Diazaspiro[4.5]decane-8-carboxylic acid, 2-(1-methylethyl)-, 1,1-dimethylethyl ester manufacturer CMO services mainly involve four stages: pre-clinical research, clinical trials, sales of patented drugs after listing, and sales of original drug products after patents expire. Its advantages are: lower cost, guaranteed quality, good capacity flexibility, and favorable process Promotion. 2,8-Diazaspiro[4.5]decane-8-carboxylic acid, 2-(1-methylethyl)-, 1,1-dimethylethyl ester supplier There were no cases of hospitalization or death among people who received the vaccine, the company reported. Side effects were mild — fatigue, headaches and muscle pain — and reactions tended to be less frequent than those triggered by some already authorized vaccines, the company said. 2,8-Diazaspiro[4.5]decane-8-carboxylic acid, 2-(1-methylethyl)-, 1,1-dimethylethyl ester vendor It is frequently associated with the presence of blasts or leukemic cells in the marrow. 2,8-Diazaspiro[4.5]decane-8-carboxylic acid, 2-(1-methylethyl)-, 1,1-dimethylethyl ester factory The findings challenge past, smaller studies that found Black women face a greater genetic risk and the suggestion that race should be an independent factor when considering genetic testing,” said study first author Dr. Susan Domchek, executive director of the Basser Center for BRCA at the University of Pennsylvania’s Perelman School of Medicine.
“We shouldn’t make changes to testing guidelines based on race alone,” she said in a university news release. “Rather, our efforts should focus on ensuring equal access to and uptake of testing to minimize disparities in care and outcomes.